NCT02177305View on ClinicalTrials.gov

Dose Tolerance Study After Ocular Administration of Tiotropium in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

October 31, 1998

Primary Completion Date

December 31, 1998

Conditions
Healthy
Interventions
DRUG

0.02 mcg tiotropium solution

DRUG

0.04 mcg tiotropium solution

DRUG

0.08 mcg tiotropium solution

DRUG

0.16 mcg tiotropium solution

DRUG

0.28 mcg tiotropium solution

DRUG

0.40 mcg tiotropium solution

DRUG

Placebo solution

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02177305 - Dose Tolerance Study After Ocular Administration of Tiotropium in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter